Microbiology & Virology Market Research Reports & Industry Analysis
One of the main focuses in virology is the study of viral infectious diseases including: rhinoviruses (common cold), influenza (flu), Herpes (simplex, zoster and varicella-zoster), AIDS (autoimmune deficiency virus), Human Papillomavirus (HPV), rabies and measles.
Some viruses, known as oncoviruses, are known to be cancer causing. The most widely studied example is the link between HPV, a sexually transmitted virus, and cervical cancer.
There are more then 150 strains of HPV, over 40 of which are sexually transmitted. Certain types of “high-risk” sexually transmitted HPV viruses can lead to cell mutations and cause cervical cancer as well as cancer of the vagina, vulva, penis and anus. Research shows that these high-risk HPV viruses cause over 99% of cervical cancers.
According to the National Cancer Institute, it is estimated that in 2010 about 12,000 women in the United States were diagnosed with cervical cancer and more than 4000 would die from it.
Although there are no treatments available for HPV, the FDA approved Cervarix and Gardisil, vaccines used to protect against the types of HPV that most commonly cause cervical cancer.
Microbiology & Virology Industry Research & Market Reports
-
Diagnostic Specialty Antibodies Market by Antibody (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies), Application (Dengue Diagnostics, Hepatitis Diagnosis, HIV Diagnostics), End User - Global Forecast 2024-2030
... USD 23.11 billion in 2023 and expected to reach USD 24.36 billion in 2024, at a CAGR 5.49% to reach USD 33.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Zoonotic Disease Treatment Market by Disease Type (Rabies, Tuberculosis, Viral Hepatitis), Drug Class (Antibacterial Medication, Antibiotics) - Global Forecast 2024-2030
... expected to reach USD 42.99 billion in 2024, at a CAGR 5.45% to reach USD 59.18 billion by 2030. Global Zoonotic Disease Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
STD Testing Market by Type (Blood Tests, Lumbar Puncture, Swab Tests), Disease type (Chlamydia, Genital herpes, Gonorrhea), Product Type, Settings, End-user - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 99.74 billion in 2024, at a CAGR 5.90% to reach USD 141.12 billion by 2030. Global STD Testing Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
In-Vitro Diagnostics Instrument Market by Product (Clinical Microbiology, Hematology, Hemostasis), End User (Academic & Research Institutes, Homecare, Hospitals & Diagnostic Laboratories) - Global Forecast 2024-2030
... 24.18 billion in 2023 and expected to reach USD 26.23 billion in 2024, at a CAGR 8.58% to reach USD 43.04 billion by 2030. Global In-Vitro Diagnostics Instrument Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Single Cell Sequencing Market by Product (Consumables, Instruments), Application (Immunology, Microbiology, Neurology), End-User - Global Forecast 2024-2030
... USD 2.64 billion in 2024, at a CAGR 4.87% to reach USD 3.51 billion by 2030. Global Single Cell Sequencing Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Single Cell ... Read More
-
Pneumonia Testing Market by Type (Instruments, Reagents & Consumables), Method (Immunodiagnostics, Molecular Diagnostics, Point of Care Testing), Technology, End-user - Global Forecast 2024-2030
... 2023 and expected to reach USD 1.58 billion in 2024, at a CAGR 6.23% to reach USD 2.28 billion by 2030. Global Pneumonia Testing Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Legionella Testing Market by Test (Culture Methods, Direct Fluorescent Antibody Test, Nucleic Acid-Based Detection), Application (Clinical Testing Methods, Environmental Testing Methods), End-User - Global Forecast 2024-2030
... 354.37 million in 2023 and expected to reach USD 385.86 million in 2024, at a CAGR 8.97% to reach USD 646.96 million by 2030. Global Legionella Testing Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis A, Hepatitis B, Hepatitis C), Technology (Enzyme-Linked Immunosorbent Assay, Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction), End-User - Global Forecast 2024-
... size was estimated at USD 3.53 billion in 2023 and expected to reach USD 3.71 billion in 2024, at a CAGR 5.48% to reach USD 5.13 billion by 2030.The hepatitis test solutions/ diagnosis are used ... Read More
-
Tuberculosis Testing Market by Test (Culture Based Tests, Drug Susceptibility Testing, Nucleic Acid Testing), End User (Hospital, Laboratories) - Global Forecast 2024-2030
... and expected to reach USD 2.76 billion in 2024, at a CAGR 7.38% to reach USD 4.23 billion by 2030. Global Tuberculosis Testing Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Tuberculosis Diagnostics Market by Test Type (Drug-susceptibility Testing, Laboratory Methods, Mantoux Test), Type (Point-of-Care Technologies, Rapid Test), End_User - Global Forecast 2024-2030
... and expected to reach USD 3.17 billion in 2024, at a CAGR 5.48% to reach USD 4.38 billion by 2030. Global Tuberculosis Diagnostics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Women’s Health Diagnostics Market by Type (Point-of-Care, Self Check), Application (Breast Cancer Testing, Cervical Cancer Testing, Infectious Disease Testing), End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 46.82 billion in 2024, at a CAGR 9.25% to reach USD 80.59 billion by 2030. Global Women’s Health Diagnostics Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Hepatitis Therapeutics Global Market Report 2024
... ProvidersCovering: Gilead Sciences Inc.; Bristol-Myers Squibb Co.; AbbVie Inc.; Merck & Co. Inc.; Johnson & Johnson Services Inc. Hepatitis Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
Lyme Disease Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
... clinic, pathology lab, pharmaceutical industry, and clinical research institute markets. The global lyme disease diagnostic market is expected to reach an estimated $1.8 billion by 2030 with a CAGR of 3.6% from 2024 to 2030. ... Read More
-
Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Research Report 2024(Status and Outlook)
... performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patients without having a direct therapeutic effect. Hence, they play a significant role in ... Read More
-
Global Immunoassay Market Size study & Forecast, by Product (Reagents & Kits, Analyzers/Instruments, Software & Services), by Technology (Radioimmunoassay (RIA), Enzyme Immunoassays (EIA) Rapid Test, Others), by End-use (Therapeutic Drug, Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases), by Application (Hospitals, Blood Banks, Clinical Laboratories, Others), by Form (Natural Immunoassay, Synthetic Immunoassay) and Regional Analysis, 2023-2030
... Disease Testing, Autoimmune Diseases), by Application (Hospitals, Blood Banks, Clinical Laboratories, Others), by Form (Natural Immunoassay, Synthetic Immunoassay) and Regional Analysis, 2023-2030 Global Immunoassay Market is valued at approximately USD XX billion in 2022 and ... Read More
-
Global Microbiology Testing Market Research Report 2024(Status and Outlook)
... exhibiting a CAGR of 2.50% during the forecast period. This report provides a deep insight into the global Microbiology Testing market covering all its essential aspects. This ranges from a macro overview of the market ... Read More
-
Global Tuberculosis (TB) Diagnostics Market Research Report 2024(Status and Outlook)
... other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about ... Read More
-
Infectious Disease Diagnostics Market based on by Product (Assays & Reagents, Instruments, and Software), Disease Type (Hepatitis, Human Immunodeficiency Virus, Influenza, and Others), and Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Next Generation Sequencing, and Others),Regional Outlook– Global Forecast up to 2030
... Others),Regional Outlook– Global Forecast up to 2030 For efficient treatment and management, diseases such as TB, HIV/AIDS, hepatitis, sexually transmitted infections, and respiratory infections require an accurate and prompt diagnosis. Early detection of these disorders ... Read More
-
Global Pharmaceutical Microbiology Testing Service Market Research Report 2024(Status and Outlook)
... is performed by specialized laboratories that have the expertise and equipment to identify and quantify microorganisms in pharmaceutical products. The Global Pharmaceutical Microbiology Testing Service Market Size was estimated at USD 5661.86 million in 2023 ... Read More
-
Global Mycoplasma Testing Market Size study & Forecast, by Product (Instruments, Kits and Reagents), by Technology (PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies), by Application (Cell Line Testing, Bioproduction Testing, Other Applications) and Regional Analysis, 2023-2030
... Analysis, 2023-2030 Global Mycoplasma Testing Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030 Mycoplasma ... Read More
-
Molecular Diagnostics in Infectious Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... East and Africa) Polymerase Chain Reaction (PCR) Segment Leading the Market Growth • North America Emerging as Dominant Region The global molecular diagnostics in infectious disease testing market, valued at US$ 57 billion in 2024, ... Read More
-
Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Global Forecast to 2028
... 2028 The infectious disease diagnostics market is valued at an estimated USD 21.4 billion in 2023 and is projected to reach USD 31.5 billion by 2028 at a CAGR of 8.0% during the forecast period. ... Read More
-
Mycoplasma Testing Market Size, Share & Trends Analysis By Product (Instruments, Kits & Reagents), By Technology (PCR, ELISA, Direct Assay, Microbial Culture), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
... Testing Market Growth & Trends The global mycoplasma testing market size is expected to reach USD 2.26 billion by 2030, registering a CAGR of 13.58% over the forecast period, according to a new report by ... Read More
-
Global Fungal Infection Diagnosis Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Fungal Infection Diagnosis industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Fungal Infection Diagnosis. The report also introduces players ... Read More
-
Liver Disease Diagnostics Market Forecasts to 2030 – Global Analysis By Disease Type (Viral Hepatitis, Alcoholic Liver Disease, Non-alcoholic Fatty Liver Disease (NAFLD), Liver Cancer and Other Disease Types), Technique (Endoscopy, Biopsy, Imaging Techniques, Laboratory Tests and Other Techniques), End User (Hospitals, Laboratories, Research Institutes and Other End Users) and by Geography
... Tests and Other Techniques), End User (Hospitals, Laboratories, Research Institutes and Other End Users) and by Geography According to Stratistics MRC, the Global Liver Disease Diagnostics Market is accounted for $40.32 billion in 2023 and ... Read More
Research Assistance
